Results of patient specific quality assurance for patients undergoing stereotactic ablative radiotherapy for lung lesions
Nicholas Hardcastle, Natalie Clements, Brent Chesson, Yolanda Aarons, Jim Cramb, Shankar Siva, Derrick M Wanigaratne, David Ball, Tomas Kron
AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE | SPRINGER | Published : 2014
Hypofractionated image guided radiotherapy of extracranial targets has become increasingly popular as a treatment modality for inoperable patients with one or more small lesions, often referred to as stereotactic ablative body radiotherapy (SABR). This report details the results of the physical quality assurance (QA) program used for the first 33 lung cancer SABR radiotherapy 3D conformal treatment plans in our centre. SABR involves one or few fractions of high radiation dose delivered in many small fields or arcs with tight margins to mobile targets often delivered through heterogeneous media with non-coplanar beams. We have conducted patient-specific QA similar to the more common intensity..View full abstract
Awarded by Cancer Australia Priority-Driven Collaborative Cancer
This work was supported by Cancer Australia Priority-Driven Collaborative Cancer Research Scheme grant 566813 in support of the CHISEL (TROG 09.02) clinical trial.